Advertisement
Screener

DEXCOM, INC. (DXCM) Deferred Tax Assets, Unrealized Losses on Available-for-Sale Securities, Gross

DEXCOM, INC. Deferred Tax Assets, Unrealized Losses on Available-for-Sale Securities, Gross

DEXCOM, INC. (DXCM) had Deferred Tax Assets, Unrealized Losses on Available-for-Sale Securities, Gross of $500.00 thousand as of 2021-12-31, per its 10-K filed 2022-02-14.

Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Gross

us-gaap:DeferredTaxAssetsUnrealizedLossesOnAvailableforSaleSecuritiesGross · last filed 2022-02-14

  • 2021-12-31: Deferred Tax Assets, Unrealized Losses on Available-for-Sale Securities, Gross $500.00K.
Period endDeferred Tax Assets, Unrealized Losses on Available-for-Sale Securities, Gross
2021-12-31$500.00K
10-K · filed 2022-02-14

Similar stocks

Stock NameCountryMarket CapPE Ratio
WEST PHARMACEUTICAL SERVICES INC (WST)United States$26.288B43.14
BECTON DICKINSON & CO (BDX)United States$48.834B43.79
Solventum Corp (SOLV)United States$15.085B9.16
Penumbra Inc (PEN)United States$12.596B77.33
BAXTER INTERNATIONAL INC (BAX)United States$12.139B-10.35
GLOBUS MEDICAL INC (GMED)United States$9.977B20.03
INSULET CORP (PODD)United States$9.420B28.12
GLAUKOS Corp (GKOS)United States$9.135B-43.73
MiniMed Group, Inc. (MMED)United States$5.748B-16.85
MERIT MEDICAL SYSTEMS INC (MMSI)United States$5.212B28.44